Gå til indhold
Global sound
Biotech Matters

Biotech Matters

Ep. 6 - B-cells vs. Complement in IgAN: A Look at the Data from Kidney Week 2024 (with Dr. Vlado Perkovic)

· 31 min. · Episode 6

Episodebeskrivelse

Principal Jeff Fineberg, PhD sits down with Vlado Perkovic, MBBS, PhD, to discuss the IgA nephropathy trial data presented at Kidney Week 2024 in San Diego. Jeff begins by asking Dr. Perkovic to talk about why targeting B-cells is an attractive target, and why BAFF/APRIL might prove more promising than CD20. The two then discuss the data with two agents in development for the treatment of IgAN, atacicept (targeting BAFF/APRIL) and sibeprenlimab (targeting APRIL only). The conversation then pivots to the prospect of complement inhibition with FABHALTA® (iptacopan) in IgA nephropathy…

Website: bluestarbioadvisors.com

Live, seneste time: 6.731 sange på 2.511 stationer i 114 lande

Opdag verden gennem radioen

Flere måder at opdage på (7)

Hørt noget godt? Gem det, eller åbn det direkte i Spotify.

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
ClubixzFortsæt med at lytte